Wellmira、イオンの健康サービス「からサポ」にAIをライセンス提供

Wellmira, a Tokyo-based healthtech company founded in 2002, announced that it is licensing its AI health app technology to power "Karasapo," a new free health service being launched by Aeon and its subsidiary Aeon Health Tech. The service officially begins on July 16, 2026, and will be integrated within Aeon's iAEON app, which currently has approximately 23 million members.

"Karasapo" is built on Wellmira's "Karomama Advice AI" solution, which packages core features from Wellmira's existing "Karoamma Plus" health app into a licensable platform. The service includes four main capabilities: an AI meal image recognition system that identifies approximately 150,000 dishes from photos, a meal entry prediction function to streamline logging, health record tracking for activities like exercise and sleep, personalized meal advice based on recorded data, and recipe recommendations selected from roughly 350 options tailored to each user's profile. The service is free and focuses on helping users improve eating habits and increase physical activity through daily health management support.

The partnership represents a joint venture between Wellmira and Aeon. According to Wellmira's statement, the collaboration combines Wellmira's AI and digital health development capabilities with Aeon's established business foundation and customer network. The companies plan to analyze usage patterns and purchase data—with user consent and proper data governance—to inform better product recommendations, promotional activities, and in-store health proposals. Looking further ahead, they are considering partnerships with municipalities and medical or research institutions to support lifestyle improvement and identify regional health challenges.

Wellmira's CEO and representative director is Toshishige Watanabe. The company stated that beyond this Aeon deployment, it intends to license "Karoamma Advice AI" to other app developers and service providers to expand the reach of its health technology across the market. The service will expand to Welcia Pharmacy's group app in autumn 2026, potentially reaching additional customer bases through that retail channel.

Wellmira's licensing agreement marks a significant shift in how the healthtech company monetizes its AI capabilities. Rather than serving only its own app users, the company is now positioning "Karomama Advice AI" as a white-label solution for larger enterprises. This partnership with Aeon—Japan's one of the largest retail groups—grants immediate access to the iAEON app's approximately 23 million members, a scale that would take Wellmira years to build independently.

The partnership structure reveals an open-innovation model: Wellmira and Aeon jointly established Aeon Health Tech as a vehicle for the collaboration, combining Wellmira's AI and digital health development capabilities with Aeon's customer network and operational foundation. The service launches in mid-2026, and the planned expansion to Welcia's app signals confidence in the business model and may bring additional millions of users into the ecosystem. Wellmira has also explicitly committed to licensing the same AI technology to other app developers and service providers in the future, suggesting this partnership is a proof-of-concept for broader commercialization.

No comments yet. Be the first to share your thoughts!